在冠状动脉干预期间没有回流:叙述性审查
Sara Malakouti1,2, Ahmed Hashim1,3, Marco Frazzetto1,4
1DCB Academy, 20136 Milano, Italy.
Journal of clinical medicine
|November 27, 2025
概括
冠状动脉不回流现象是心脏手术的并发症,它阻碍了微血管输液,并使患者的结果恶化. 本综述整合了病理生理学,诊断和治疗,提出了人工智能驱动的解决方案,以改善治疗.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心血管研究研究心血管研究
背景情况:
- 冠状动脉不回流现象是穿皮冠状动脉干预期间的严重并发症,特别是在急性冠状动脉综合征中.
- 尽管恢复了心上动脉的流量,但受损的微血管输液导致心力衰竭和死亡率增加等不良事件.
- 目前对多因素病理生理学和治疗策略的理解仍然不完整.
研究的目的:
- 为冠状动脉不回流的多因素病理生理学提供综合的视角.
- 审查诊断成像和治疗选择管理这种情况的进展.
- 探索未来的方向,包括基于人工智能的预测建模和有针对性的微血管治疗.
主要方法:
- 综合病理生理学,诊断成像和治疗干预的综合文献综述.
- 系统性炎症,血栓发生性,缺血-再输血损伤和远端栓塞的分析.
- 评估当前和新兴的治疗方法,包括抗血栓剂,血管扩张剂和机械辅助剂.
主要成果:
- 没有反流涉及复杂的相互作用的炎症,凝血,再注射损伤,和栓塞.
- 像心脏MRI和CT等先进的成像技术有助于诊断和理解.
- 现有疗法存在局限性,突出未满足的临床需求.
结论:
- 个性化治疗方法对于改善冠状动脉无反流患者的治疗结果至关重要.
- 未来的研究应该专注于人工智能用于预测建模和新的微血管疗法.
- 解决不回流问题对于降低死亡率和改善长期心血管健康至关重要.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206


